Jasper Therapeutics Inc (JSPR)

Dec 21, 2024

Wellington Management Group LLP Buys New Position in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Dec 21, 2024

Dec 18, 2024

(JSPR) Trading Signals - Stock Traders Daily

Dec 18, 2024

Dec 18, 2024

Fmr LLC Makes New $722,000 Investment in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Dec 18, 2024

Dec 15, 2024

Jasper Therapeutics' SWOT analysis: briquilimab's promise lifts stock outlook - Investing.com India

Dec 15, 2024

Dec 15, 2024

Jasper Therapeutics' SWOT analysis: briquilimab's promise lifts stock outlook By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 13, 2024

Head to Head Contrast: Jasper Therapeutics (NASDAQ:JSPR) versus Immunovant (NASDAQ:IMVT) - Defense World

Dec 13, 2024

Dec 12, 2024

Jasper Therapeutics COO Mahal Singh sells $19,899 in stock - Investing.com

Dec 12, 2024

Dec 12, 2024

Jasper Therapeutics COO Mahal Singh sells $19,899 in stock By Investing.com - Investing.com UK

Dec 12, 2024

Dec 12, 2024

Verition Fund Management LLC Invests $477,000 in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Dec 12, 2024

Dec 10, 2024

Analysts Set Jasper Therapeutics, Inc. (NASDAQ:JSPR) Target Price at $73.38 - Defense World

Dec 10, 2024

Dec 08, 2024

When (JSPR) Moves Investors should Listen - Stock Traders Daily

Dec 08, 2024

Dec 08, 2024

BMO Capital Markets Initiates Coverage on Jasper Therapeutics (NASDAQ:JSPR) - Defense World

Dec 08, 2024

Dec 07, 2024

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Dec 07, 2024

Dec 07, 2024

Jasper Therapeutics (NASDAQ:JSPR) versus PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Comparison - Defense World

Dec 07, 2024

Dec 06, 2024

BMO Capital Initiates Coverage of Jasper Therapeutics (JSPR) with Outperform Recommendation - MSN

Dec 06, 2024

Dec 06, 2024

BMO Capital Markets Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR) - MarketBeat

Dec 06, 2024

Dec 05, 2024

Jasper Therapeutics shares rise on BMO's Outperform rating By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 05, 2024

Samsara BioCapital LLC Boosts Stock Position in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Short Interest Up 10.2% in November - Defense World

Dec 04, 2024

Dec 02, 2024

Jasper Therapeutics, Inc. Doses First Patient in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma - Marketscreener.com

Dec 02, 2024

Dec 02, 2024

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma - GlobeNewswire

Dec 02, 2024

Dec 02, 2024

Jasper Therapeutics Launches Phase 1b/2a Asthma Trial, Expands Briquilimab Program | JSPR Stock News - StockTitan

Dec 02, 2024

Nov 30, 2024

Braidwell LP Invests $9.09 Million in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Nov 30, 2024

Nov 28, 2024

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Purchased by Ally Bridge Group NY LLC - MarketBeat

Nov 28, 2024

Nov 27, 2024

Learn to Evaluate (JSPR) using the Charts - Stock Traders Daily

Nov 27, 2024

Nov 27, 2024

Great Point Partners LLC Sells 79,635 Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat

Nov 27, 2024

Nov 23, 2024

Addiction Therapeutics Market to Observe Strong Growth by 2030| Abbott, Denali Therapeutics - Newstrail

Nov 23, 2024

Nov 18, 2024

Jasper Therapeutics: Briquilimab's Potential In Chronic Urticaria And Asthma (NASDAQ:JSPR) - Seeking Alpha

Nov 18, 2024

Nov 16, 2024

We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate - Yahoo Finance

Nov 16, 2024

Nov 16, 2024

Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024

Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024

Nov 13, 2024

Jasper Therapeutics' SWOT analysis: briquilimab's potential reshapes mast cell stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Jasper Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Jasper Therapeutics to Present Briquilimab Updates at Major Healthcare Conferences | JSPR Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

Analysts Set Jasper Therapeutics, Inc. (NASDAQ:JSPR) Price Target at $74.86 - MarketBeat

Nov 12, 2024

Nov 10, 2024

Stifel Initiates Coverage of Jasper Therapeutics (JSPR) with Buy Recommendation - MSN

Nov 10, 2024

Nov 09, 2024

Amplitude Healthcare Acquisition (OTCMKTS:AMHCU) News: Jasper Therapeutics, Inc. Reports Third Quarter 2024 Results - Defense World

Nov 09, 2024

Nov 08, 2024

Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Jasper Therapeutics Advances in Antibody Therapy Development - TipRanks

Nov 08, 2024

Nov 07, 2024

Jasper Therapeutics Inc (JSPR) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

McDonald's Corp (MCD-N) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

TSX Oil and Gas EW Index (TXOE) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Nasdaq Other Finance Index (OFIN) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 06, 2024

(JSPR) Long Term Investment Analysis - Stock Traders Daily

Nov 06, 2024

Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire

Nov 04, 2024

Nov 03, 2024

Net Present Value Model: Jasper Therapeutics Inc’s Briquilimab - GlobalData

Nov 03, 2024

Oct 27, 2024

JSPRJasper Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 27, 2024

Oct 26, 2024

Long Term Trading Analysis for (JSPR) - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

Jasper Therapeutics' SWOT analysis: briquilimab stock shows promise amid challenges - Investing.com

Oct 25, 2024